$251.03
2.350.94%
At Close: -
$251.03
00.00%
After Hours: 4:38 PM EDT
15 minutes delayed
Alnylam Pharmaceuticals (NASDAQ:ALNY) 주식, 실적 예상치, EPS, 및 매출
Alnylam Pharmaceuticals은(는) 분기별로 실적을 보고합니다. 이 분기별 실적 보고서를 통해 투자자는 3개월 동안 회사의 재무 결과를 엿볼 수 있습니다. 실적 보고서에는 거의 항상 EPS 및 매출 결과가 포함됩니다..
실적 발표일
8월 1
EPS 추정치
$-1.100
분기 매출 예상치
$446M
연간 매출
(기준 3월 31)
(기준 3월 31)
$2B
Alnylam Pharmaceuticals의 실적 이력을 고급 정렬 및 필터를 사용하여 분석하십시오.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals | -$1.62 | -$1.10 | — | — | $318.75M | $445.98M | — | — | 08/01/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.06 | -$1.18 | -$0.16 | 86.44% | $319.29M | $427.33M | $494.33M | 15.68% | 05/02/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.39 | -$1.33 | -$0.77 | 42.11% | $335.04M | $442.90M | $439.72M | -0.72% | 02/15/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.58 | -$1.36 | $1.74 | 227.94% | $264.31M | $401.03M | $750.53M | 87.15% | 11/02/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$2.03 | -$1.72 | -$1.62 | 5.81% | $224.82M | $331.73M | $318.75M | -3.91% | 08/03/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.49 | -$1.76 | -$1.06 | 39.77% | $213.26M | $312.26M | $319.29M | 2.25% | 05/04/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.74 | -$1.90 | -$1.39 | 26.84% | $258.54M | $313.13M | $335.04M | 7.00% | 02/23/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.59 | -$1.78 | -$1.58 | 11.24% | $187.63M | $293.03M | $264.31M | -9.80% | 10/27/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.30 | -$1.62 | -$2.03 | -25.31% | $220.55M | $255.88M | $224.82M | -12.14% | 07/28/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.64 | -$1.84 | -$1.49 | 19.02% | $135.77M | $243.02M | $213.26M | -12.25% | 04/28/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.60 | -$1.54 | -$1.69 | -9.74% | $163.56M | $233.62M | $258.54M | 10.66% | 02/10/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.58 | -$1.57 | -$1.51 | 3.82% | $125.85M | $218.69M | $187.63M | -14.20% | 10/28/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.67 | -$1.60 | -$1.30 | 18.75% | $103.96M | $193.18M | $220.55M | 14.17% | 08/03/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.52 | -$1.75 | -$1.64 | 6.29% | $99.48M | $168.74M | $177.57M | 5.23% | 04/29/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.98 | -$1.76 | -$1.60 | 9.09% | $71.68M | $146.07M | $163.56M | 11.98% | 02/11/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.50 | -$1.66 | -$1.58 | 4.82% | $70.06M | $120.75M | $125.85M | 4.23% | 11/05/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.83 | -$1.74 | -$1.67 | 4.02% | $44.71M | $99.48M | $103.96M | 4.51% | 08/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.73 | -$1.89 | -$1.52 | 19.58% | $33.29M | $91.56M | $99.48M | 8.65% | 05/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.82 | -$2.23 | -$1.98 | 11.21% | $21.03M | $72.00M | $71.68M | -0.44% | 02/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.56 | — | -$1.50 | — | $2.07M | — | $70.06M | — | 10/31/2019 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.61 | -$1.86 | -$1.83 | 1.61% | $29.91M | $69.20M | $44.71M | -35.38% | 08/06/2019 | Get Alert |
Alnylam Pharmaceuticals (ALNY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.16 | $-1.18 | 86.4 % |
| Dec 2023 | 2024-02-15 | $-0.77 | $-1.33 | 42.1 % |
| Sep 2023 | 2023-11-02 | $1.74 | $-1.36 | 227.9 % |
| Jun 2023 | 2023-08-03 | $-1.62 | $-1.72 | 5.81 % |
Alnylam Pharmaceuticals (ALNY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $494.33M | $427.33M | 15.7 % |
| Dec 2023 | 2024-02-15 | $439.72M | $442.90M | -0.72 % |
| Sep 2023 | 2023-11-02 | $750.53M | $401.03M | 87.2 % |
| Jun 2023 | 2023-08-03 | $318.75M | $331.73M | -3.91 % |
FAQ
Alnylam Pharmaceuticals (NASDAQ:ALNY)의 실적 발표는 언제인가요?
Alnylam Pharmaceuticals (ALNY)의 실적 발표가 8월 1, 2024에 예정되어 있습니다. 마지막으로 보고된 실적은 5월 2, 2024에 Q1에 대해 보고되었습니다.
Alnylam Pharmaceuticals (NASDAQ:ALNY)의 최신 주당 순이익(EPS)은 얼마인가요?
실제 EPS는 $-0.16이며, 이는 $-1.18의 추정치를 뛰어넘다합니다.
Alnylam Pharmaceuticals (NASDAQ:ALNY)의 매출은 얼마인가요?
실제 매출은 $494.3M이었으며, 이는 $427.3M의 추정치를 뛰어넘다합니다.
검색 실적 예상치, EPS, 및 매출 모든 주식에 대한
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved